Literature DB >> 6119509

Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno study group.

.   

Abstract

The effect of 6 months of strict metabolic control upon eye and kidney function was studied in 32 insulin-dependent diabetics randomised either to unchanged conventional treatment (UCT) or to continuous subcutaneous insulin infusion (CSII). Retinal function was assessed by means of the macular recovery time (measured with nyctometry), the oscillatory potential (measured with electroretinography), and fluorophotometry. Renal function was assessed by the glomerular filtration rate (GFR) and the urinary albumin excretion rate. Individual median blood-glucose levels during the 6 months were 9.2 +/- 2.0 mmol/l (mean +/- SD) in the UCT group and 5.6 +/- 0.7 mmol/l in the CSII group. Haemoglobin Alc fell from 8.8 +/- 1.2 to 8.0 +/- 2% in the UCT group and from 9.6 +/- 1.7 to 6.7 +/- 1.0% in the CSII group. The UCT group showed a significant deterioration in all indices of retinal function (macular recovery -6%, oscillatory potential -5%, fluorophotometry +9%, whereas patients treated with CSII showed a distinct improvement (macular recovery +5%, oscillatory potential +7%, fluorophotometry -7%). GFR fell by 9% with CSII and rose 2% with UCT. Urinary albumin excretion fell by 12% with CSII and rose by 56% with UCT. This interim report of a one-year study supports the view that long-term control achieving near-normal blood-glucose levels may arrest or even reverse some of the features associated with diabetic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6119509

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

Review 1.  Can hypoglycaemia be predicted before its onset?

Authors:  P Lönnroth
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

Review 2.  Glycemic memories and the epigenetic component of diabetic nephropathy.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

3.  Diabetic complications: tight control versus increasingly tight science.

Authors:  R B Haynes
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

Review 4.  Technology and the diabetic patient.

Authors:  J C Pickup; D Rothwell
Journal:  Med Biol Eng Comput       Date:  1984-09       Impact factor: 2.602

5.  Continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.

Authors:  M Varghese; K Walshe; P M Bell; D R Hadden; A L Kennedy; J A Weaver
Journal:  Ir J Med Sci       Date:  1983-02       Impact factor: 1.568

6.  Retinopathy is associated with higher glycaemia in maturity-onset type diabetes.

Authors:  J Howard-Williams; R M Hillson; A Bron; P Awdry; J I Mann; T D Hockaday
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

7.  Blood glucose and diabetic retinopathy: a critical appraisal of new evidence.

Authors:  C D Mulrow; M J Lichtenstein
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

8.  Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.

Authors:  Mark E Molitch; Michael Steffes; Wanjie Sun; Brandy Rutledge; Patricia Cleary; Ian H de Boer; Bernard Zinman; John Lachin
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

9.  Diabetic nephropathy: clinical and histological study in 22 patients.

Authors:  S Bertoli; R Bottelli; R Confalonieri; L Radaelli; C Rovati; G Barbiano di Belgiojoso; G Micoli
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

10.  A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.

Authors:  Johan Wadén; Carol Forsblom; Lena M Thorn; Daniel Gordin; Markku Saraheimo; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.